Current dichotomy between traditional molecular biological and omic research in cancer biology and pharmacology
- PMID: 26677427
- PMCID: PMC4675899
- DOI: 10.5306/wjco.v6.i6.184
Current dichotomy between traditional molecular biological and omic research in cancer biology and pharmacology
Abstract
There is currently a split within the cancer research community between traditional molecular biological hypothesis-driven and the more recent "omic" forms or research. While the molecular biological approach employs the tried and true single alteration-single response formulations of experimentation, the omic employs broad-based assay or sample collection approaches that generate large volumes of data. How to integrate the benefits of these two approaches in an efficient and productive fashion remains an outstanding issue. Ideally, one would merge the understandability, exactness, simplicity, and testability of the molecular biological approach, with the larger amounts of data, simultaneous consideration of multiple alterations, consideration of genes both of known interest along with the novel, cross-sample comparisons among cell lines and patient samples, and consideration of directed questions while simultaneously gaining exposure to the novel provided by the omic approach. While at the current time integration of the two disciplines remains problematic, attempts to do so are ongoing, and will be necessary for the understanding of the large cell line screens including the Developmental Therapeutics Program's NCI-60, the Broad Institute's Cancer Cell Line Encyclopedia, and the Wellcome Trust Sanger Institute's Cancer Genome Project, as well as the the Cancer Genome Atlas clinical samples project. Going forward there is significant benefit to be had from the integration of the molecular biological and the omic forms or research, with the desired goal being improved translational understanding and application.
Keywords: Cancer; Integration; Molecular biology; Omic; Pharmacology.
Similar articles
-
Searching for pharmacogenomic markers: the synergy between omic and hypothesis-driven research.Dis Markers. 2001;17(2):77-88. doi: 10.1155/2001/435746. Dis Markers. 2001. PMID: 11673654 Free PMC article. Review.
-
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. PMID: 26269925 Free Books & Documents. Review.
-
The integration of 'omic' disciplines and systems biology in cattle breeding.Animal. 2011 Feb;5(4):493-505. doi: 10.1017/S1751731110002120. Animal. 2011. PMID: 22439945
-
Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties.BMC Syst Biol. 2013 Feb 19;7:14. doi: 10.1186/1752-0509-7-14. BMC Syst Biol. 2013. PMID: 23418673 Free PMC article.
-
Integrating multi-omic features exploiting Chromosome Conformation Capture data.Front Genet. 2015 Feb 11;6:40. doi: 10.3389/fgene.2015.00040. eCollection 2015. Front Genet. 2015. PMID: 25717338 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources